Trials / Sponsors / Quanli Gao
Quanli Gao
Other Government · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC Non-small Cell Lung Cancer | Phase 2 | 2022-09-16 |
| Recruiting | The Immune Assessment of PD-1 Antibody Therapy in Tumor Efficacy, Team, Adverse Event | — | 2021-07-01 |
| Terminated | L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma Malignant Melanoma | Phase 2 | 2021-07-01 |